Your browser doesn't support javascript.
loading
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease.
Carlsen, Arne; Omdal, Roald; Karlsen, Lars; Kvaløy, Jan Terje; Aabakken, Lars; Steinsbø, Øyvind; Bolstad, Nils; Warren, David; Lundin, Knut Erik Aslaksen; Grimstad, Tore.
Afiliação
  • Carlsen A; Gastroenterology Unit, Department of Internal Medicine Stavanger University Hospital Stavanger Norway.
  • Omdal R; Department of Clinical Science, Faculty of Medicine University of Bergen Bergen Norway.
  • Karlsen L; Department of Clinical Science, Faculty of Medicine University of Bergen Bergen Norway.
  • Kvaløy JT; Clinical Immunology Unit, Department of Internal Medicine Stavanger University Hospital Stavanger Norway.
  • Aabakken L; Gastroenterology Unit, Department of Internal Medicine Stavanger University Hospital Stavanger Norway.
  • Steinsbø Ø; Department of Mathematics and Physics University of Stavanger Stavanger Norway.
  • Bolstad N; Research Department Stavanger University Hospital Stavanger Norway.
  • Warren D; Department of Transplantation Medicine Oslo University Hospital Rikshospitalet Oslo Norway.
  • Lundin KEA; Gastroenterology Unit, Department of Internal Medicine Stavanger University Hospital Stavanger Norway.
  • Grimstad T; Department of Clinical Science, Faculty of Medicine University of Bergen Bergen Norway.
JGH Open ; 4(3): 410-416, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32514446

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article